European shares slip on caution around vaccine trials, stimulus

Reuters

Published Oct 14, 2020 08:26

(Reuters) - European shares headed lower on Wednesday after tumbling in the previous session over a halt in COVID-19 vaccine trials and uncertainty over more U.S. stimulus, with investors also staying away from big bets ahead of talks on a Brexit trade deal.

The pan-European STOXX 600 (STOXX) was down 0.2% by 0708 GMT, with travel and leisure (SXTP) and insurance (SXIP) stocks leading early declines.

Although trading in most country indexes was muted, a weaker pound lifted London's FTSE 100 (FTSE) by 0.2% ahead of a UK-imposed Oct. 15 deadline on Brexit negotiations. Growing political friction about the impact of new local COVID-19 restrictions has also hit sentiment. (L)

The European Union would prefer to have a deal, but it is ready in case no agreement can be reached, the Commissioner for the EU's single market said.